TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 0 | -1 | -8 | -1 | 7 | 2 | -0 |
| S | %wins | 67 | 67 | 67 | 67 | 33 | 67 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/13 12:16 | 5/14/13 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Li Lin Ling | F4 | H | See Rema | S | -62,258 | 20.00 | 1 | -3,113 | -67 | 1,530 | D | 79 | 178 | 131 | 42 | -4 | -2 | -3 | -2 | 1 | 3 | -12 | -7 | 10 | 57 | |
12/14/10 15:35 | 12/10/10 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Li Lin Ling | F4 | DT | S | -19,500 | 13.00 | 2 | -1,500 | -25 | 4,593 | D | 686 | 71 | 34 | 49 | 61 | 54 | 36 | 15 | -1 | -2 | 2 | -2 | -36 | -26 | ||
9/3/10 13:56 | 8/31/10 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Li Lin Ling | F4 | DT | S.d | -10,010 | 13.00 | 1 | -770 | -11 | 6,143 | D | 255 | 93 | 15 | -14 | -1 | -15 | -7 | 3 | 0 | -4 | -15 | 5 | 47 | -26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |